title: Should monitoring of vancomycin be delayed? A case of likely nephrotoxicity occasioned by morbid obesity and minimal monitoring.
authors.affiliation: Pharmacy Department, The Queen Elizabeth Hospital, 28 Woodville Rd, Woodville South, South Australia 5011, Australia. terry.jones@health.sa.gov.au
authors.forename: Terry E
authors.initials: TE
authors.lastname: Jones
authors.forename: Hayley
authors.initials: H
authors.lastname: Vasileff
authors.forename: Cassie
authors.initials: C
authors.lastname: Hewton
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D001835:Body Weight; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D009767:Obesity, Morbid / Q000150:complications*; D014640:Vancomycin / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin